Focus on Pradaxa
Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran.
The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
My Articles About Pradaxa
A Primary Focus Is Gastrointestinal And Intracranial Hemorrhages In Patients Using Pradaxa For Atrial Fibrillation
SUMMARY: On December 30, 2013 the FDA posted for public comment on a proposed protocol of a new study intended to be a one-time assessment of selected safety outcomes in adults with atrial fibrillation who are new users of Pradaxa (dabigatran) or Coumadin (warfarin).
Some background information about this Pradaxa FDA study of can be found in a January 3, 2014 Forbes article by Larry Husten, "FDA Plans New Safety Assessment Of Dabigatran (Pradaxa)".
We will be watching the FDA and the medical news reports for future developments concerning this latest FDA safety review regarding Pradaxa and serious bleeding side effects, some of which can result in death.
Earlier Pradaxa articles by Tom Lamb on the Drug Injury Watch blog:
Drug Injury Watch: Increasing Number Of Pradaxa Lawsuits Against Boehringer Are Consolidated In Federal Court MDL
Drug Injury Watch: Pradaxa Side Effects Update Mid-2012: Deaths, Hemorrhages, Acute Renal Failure, and Stroke Events Submitted To FDA MedWatch
Drug Injury Watch: Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects
Drug Injury Watch: Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings
News Regarding Pradaxa
More About Pradaxa At
Our DrugInjuryLaw.com Web Site
Visit the Pradaxa Information page at our Drug Injury Law web site for up-to-the-date developments regarding personal injury and wrongful death lawsuits that involve Pradaxa.
The Law Offices of Thomas J. Lamb, P.A. is handling personal injury and wrongful death lawsuits against the drug company when any of these medical conditions developed while using Pradaxa:
- Serious Bleeding Events
- Heart Attack or Myocardial Infarction (MI)
- Acute Coronary Syndrome (ACS)
If you or someone you know is interested in filing a claim for legal compensation, we offer a free Case Evaluation online at our Drug Injury Law web site.
In the alternative, you can call our toll-free number, (800) 426-9535, to discuss a possible Pradaxa case with attorney Tom Lamb.
DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects ______________________________________________________________________________